Polaryx Therapeutics, Inc. (PLYX)
1.61
+0.01
(+0.62%)
USD |
NASDAQ |
Nov 18, 16:00
1.61
0.00 (0.00%)
After-Hours: 20:00
Polaryx Therapeutics Shareholders Equity (Quarterly) : 7.611M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.611M |
| June 30, 2026 | 10.94M |
| March 31, 2026 | 2.488M |
| December 31, 2025 | 4.565M |
| Date | Value |
|---|---|
| September 30, 2025 | 5.301M |
| June 30, 2025 | 3.247M |
| March 31, 2025 | 4.253M |
| December 31, 2024 | 4.712M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 2.675M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 513.80M |
| Fulcrum Therapeutics, Inc. | 302.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.61M |
| Total Liabilities (Quarterly) | 0.999M |
| Current Ratio | 8.619 |